ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DPT Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-18H13230
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global DPT Vaccination Market Research Report 2023
BUY CHAPTERS

Global DPT Vaccination Market Research Report 2025

Code: QYRE-Auto-18H13230
Report
January 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology

DPT Vaccination Market Size

The global market for DPT Vaccination was valued at US$ 5567 million in the year 2024 and is projected to reach a revised size of US$ 7058 million by 2031, growing at a CAGR of 3.5% during the forecast period.

DPT Vaccination Market

DPT Vaccination Market

The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for DPT Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccination.
The DPT Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DPT Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of DPT Vaccination Market Report

Report Metric Details
Report Name DPT Vaccination Market
Accounted market size in year US$ 5567 million
Forecasted market size in 2031 US$ 7058 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 12 Months Below
  • 12 Months Above
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of DPT Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of DPT Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is DPT Vaccination Market growing?

Ans: The DPT Vaccination Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the DPT Vaccination Market size in 2031?

Ans: The DPT Vaccination Market size in 2031 will be US$ 7058 million.

Who are the main players in the DPT Vaccination Market report?

Ans: The main players in the DPT Vaccination Market are Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology

What are the Application segmentation covered in the DPT Vaccination Market report?

Ans: The Applications covered in the DPT Vaccination Market report are 12 Months Below, 12 Months Above

What are the Type segmentation covered in the DPT Vaccination Market report?

Ans: The Types covered in the DPT Vaccination Market report are DTaP, Tdap, DTwP

Recommended Reports

Pediatric & Preventable Vaccines

Combination & Multivalent Vaccines

Vaccine Technology & Delivery

1 DPT Vaccination Market Overview
1.1 Product Definition
1.2 DPT Vaccination by Type
1.2.1 Global DPT Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccination by Application
1.3.1 Global DPT Vaccination Market Value by Application (2024 VS 2031)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccination Market Size Estimates and Forecasts
1.4.1 Global DPT Vaccination Revenue 2020-2031
1.4.2 Global DPT Vaccination Sales 2020-2031
1.4.3 Global DPT Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 DPT Vaccination Market Competition by Manufacturers
2.1 Global DPT Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global DPT Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global DPT Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of DPT Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DPT Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DPT Vaccination, Product Type & Application
2.7 Global Key Manufacturers of DPT Vaccination, Date of Enter into This Industry
2.8 Global DPT Vaccination Market Competitive Situation and Trends
2.8.1 Global DPT Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest DPT Vaccination Players Market Share by Revenue
2.8.3 Global DPT Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global DPT Vaccination Market Scenario by Region
3.1 Global DPT Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global DPT Vaccination Sales by Region: 2020-2031
3.2.1 Global DPT Vaccination Sales by Region: 2020-2025
3.2.2 Global DPT Vaccination Sales by Region: 2026-2031
3.3 Global DPT Vaccination Revenue by Region: 2020-2031
3.3.1 Global DPT Vaccination Revenue by Region: 2020-2025
3.3.2 Global DPT Vaccination Revenue by Region: 2026-2031
3.4 North America DPT Vaccination Market Facts & Figures by Country
3.4.1 North America DPT Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America DPT Vaccination Sales by Country (2020-2031)
3.4.3 North America DPT Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe DPT Vaccination Market Facts & Figures by Country
3.5.1 Europe DPT Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe DPT Vaccination Sales by Country (2020-2031)
3.5.3 Europe DPT Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DPT Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific DPT Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific DPT Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific DPT Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DPT Vaccination Market Facts & Figures by Country
3.7.1 Latin America DPT Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America DPT Vaccination Sales by Country (2020-2031)
3.7.3 Latin America DPT Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DPT Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa DPT Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa DPT Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa DPT Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DPT Vaccination Sales by Type (2020-2031)
4.1.1 Global DPT Vaccination Sales by Type (2020-2025)
4.1.2 Global DPT Vaccination Sales by Type (2026-2031)
4.1.3 Global DPT Vaccination Sales Market Share by Type (2020-2031)
4.2 Global DPT Vaccination Revenue by Type (2020-2031)
4.2.1 Global DPT Vaccination Revenue by Type (2020-2025)
4.2.2 Global DPT Vaccination Revenue by Type (2026-2031)
4.2.3 Global DPT Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global DPT Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global DPT Vaccination Sales by Application (2020-2031)
5.1.1 Global DPT Vaccination Sales by Application (2020-2025)
5.1.2 Global DPT Vaccination Sales by Application (2026-2031)
5.1.3 Global DPT Vaccination Sales Market Share by Application (2020-2031)
5.2 Global DPT Vaccination Revenue by Application (2020-2031)
5.2.1 Global DPT Vaccination Revenue by Application (2020-2025)
5.2.2 Global DPT Vaccination Revenue by Application (2026-2031)
5.2.3 Global DPT Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global DPT Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur DPT Vaccination Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK DPT Vaccination Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Company Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccination Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Company Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 KM Biologics DPT Vaccination Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Company Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuhan Institute of Biological Products DPT Vaccination Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology DPT Vaccination Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.7.1 Chengdu Institute of Biological Products Company Information
6.7.2 Chengdu Institute of Biological Products Description and Business Overview
6.7.3 Chengdu Institute of Biological Products DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Institute of Biological Products DPT Vaccination Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Company Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology DPT Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Minhai Biotechnology DPT Vaccination Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DPT Vaccination Industry Chain Analysis
7.2 DPT Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DPT Vaccination Production Mode & Process Analysis
7.4 DPT Vaccination Sales and Marketing
7.4.1 DPT Vaccination Sales Channels
7.4.2 DPT Vaccination Distributors
7.5 DPT Vaccination Customer Analysis
8 DPT Vaccination Market Dynamics
8.1 DPT Vaccination Industry Trends
8.2 DPT Vaccination Market Drivers
8.3 DPT Vaccination Market Challenges
8.4 DPT Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
List of Tables
 Table 1. Global DPT Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global DPT Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global DPT Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global DPT Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global DPT Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global DPT Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global DPT Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market DPT Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of DPT Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of DPT Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of DPT Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of DPT Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global DPT Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global DPT Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global DPT Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global DPT Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global DPT Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global DPT Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global DPT Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global DPT Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global DPT Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global DPT Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America DPT Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America DPT Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America DPT Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America DPT Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America DPT Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe DPT Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe DPT Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe DPT Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe DPT Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe DPT Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific DPT Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific DPT Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific DPT Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific DPT Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific DPT Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DPT Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America DPT Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America DPT Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America DPT Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America DPT Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa DPT Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa DPT Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa DPT Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa DPT Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa DPT Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global DPT Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global DPT Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global DPT Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global DPT Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global DPT Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global DPT Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global DPT Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global DPT Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global DPT Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global DPT Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global DPT Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global DPT Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global DPT Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global DPT Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global DPT Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global DPT Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global DPT Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global DPT Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global DPT Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global DPT Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. Sanofi Pasteur Company Information
 Table 71. Sanofi Pasteur Description and Business Overview
 Table 72. Sanofi Pasteur DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Sanofi Pasteur DPT Vaccination Product
 Table 74. Sanofi Pasteur Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK DPT Vaccination Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Mitsubishi Tanabe Pharma Company Information
 Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 82. Mitsubishi Tanabe Pharma DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mitsubishi Tanabe Pharma DPT Vaccination Product
 Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 85. KM Biologics Company Information
 Table 86. KM Biologics Description and Business Overview
 Table 87. KM Biologics DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. KM Biologics DPT Vaccination Product
 Table 89. KM Biologics Recent Developments/Updates
 Table 90. Wuhan Institute of Biological Products Company Information
 Table 91. Wuhan Institute of Biological Products Description and Business Overview
 Table 92. Wuhan Institute of Biological Products DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Wuhan Institute of Biological Products DPT Vaccination Product
 Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
 Table 95. Walvax Biotechnology Company Information
 Table 96. Walvax Biotechnology Description and Business Overview
 Table 97. Walvax Biotechnology DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Walvax Biotechnology DPT Vaccination Product
 Table 99. Walvax Biotechnology Recent Developments/Updates
 Table 100. Chengdu Institute of Biological Products Company Information
 Table 101. Chengdu Institute of Biological Products Description and Business Overview
 Table 102. Chengdu Institute of Biological Products DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chengdu Institute of Biological Products DPT Vaccination Product
 Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
 Table 105. Minhai Biotechnology Company Information
 Table 106. Minhai Biotechnology Description and Business Overview
 Table 107. Minhai Biotechnology DPT Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Minhai Biotechnology DPT Vaccination Product
 Table 109. Minhai Biotechnology Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. DPT Vaccination Distributors List
 Table 113. DPT Vaccination Customers List
 Table 114. DPT Vaccination Market Trends
 Table 115. DPT Vaccination Market Drivers
 Table 116. DPT Vaccination Market Challenges
 Table 117. DPT Vaccination Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of DPT Vaccination
 Figure 2. Global DPT Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DPT Vaccination Market Share by Type: 2024 & 2031
 Figure 4. DTaP Product Picture
 Figure 5. Tdap Product Picture
 Figure 6. DTwP Product Picture
 Figure 7. Global DPT Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global DPT Vaccination Market Share by Application: 2024 & 2031
 Figure 9. 12 Months Below
 Figure 10. 12 Months Above
 Figure 11. Global DPT Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global DPT Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 13. Global DPT Vaccination Sales (2020-2031) & (K Units)
 Figure 14. Global DPT Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 15. DPT Vaccination Report Years Considered
 Figure 16. DPT Vaccination Sales Share by Manufacturers in 2024
 Figure 17. Global DPT Vaccination Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest DPT Vaccination Players: Market Share by Revenue in DPT Vaccination in 2024
 Figure 19. DPT Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global DPT Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America DPT Vaccination Sales Market Share by Country (2020-2031)
 Figure 22. North America DPT Vaccination Revenue Market Share by Country (2020-2031)
 Figure 23. United States DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe DPT Vaccination Sales Market Share by Country (2020-2031)
 Figure 26. Europe DPT Vaccination Revenue Market Share by Country (2020-2031)
 Figure 27. Germany DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific DPT Vaccination Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific DPT Vaccination Revenue Market Share by Region (2020-2031)
 Figure 34. China DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America DPT Vaccination Sales Market Share by Country (2020-2031)
 Figure 44. Latin America DPT Vaccination Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa DPT Vaccination Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa DPT Vaccination Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE DPT Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of DPT Vaccination by Type (2020-2031)
 Figure 54. Global Revenue Market Share of DPT Vaccination by Type (2020-2031)
 Figure 55. Global DPT Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of DPT Vaccination by Application (2020-2031)
 Figure 57. Global Revenue Market Share of DPT Vaccination by Application (2020-2031)
 Figure 58. Global DPT Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 59. DPT Vaccination Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global DPT Vaccines Market Research Report 2025
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2025
Global Diphtheria Tetanus and Pertussis DTaP Vaccine Market Research Report 2024
Global DPT Series Vaccine Market Research Report 2024
Diphtheria Tetanus and Acellular Pertussis Combined Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DTaP and Tdap Vaccines Market Insights Forecast to 2030
Global Component DTP Vaccine Market Research Report 2024
Global Adsorbed DTP Vaccine Market Research Report 2024
Global TD Vaccine Market Research Report 2025
Global Adsorption of DTP Combination Vaccine Market Research Report 2025
Global Acellular DTP Vaccine Market Research Report 2024
Global Pentavalent Vaccine Market Research Report 2024
Global Combined Polio Vaccine Market Research Report 2024
Global DT Based Combined Vaccines Market Research Report 2024
Global Combination Vaccines for Children Market Research Report 2024
Global DA2PP DHPP Vaccine Market Research Report 2024
Global Pertussis Vaccination Market Research Report 2025
DTaP Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DTap Hib IPV Combination Vaccine Market Research Report 2024
Global Pediatric Preventable Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions